Related Experiment Video
Updated: Jan 16, 2026

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices
Published on: September 2, 2009
Technological Aspects, Challenges and Applications of Pulsatile Drug Delivery System-A Critical Review
Acharya Balkrishna1, Shalini Mishra1, Shalini Singh2
1Patanjali Herbal Research Department, Patanjali Research Foundation, Haridwar-249405, India.
Abstract:
The medicine is constantly released via a sustained and regulated drug delivery system per unit. However, there are several situations where it is undesirable to keep a drug's blood level constant. In these circumstances, pulsatile drug delivery could be preferable. Pulsatile drug delivery systems (PDDS) are gaining popularity because they deliver the medicine to the correct site of action at the proper time and in the right amount, offering spatial and temporal delivery and boosting patient compliance. These are essentially time-controlled drug delivery systems in which the system manages the lag time independent of environmental parameters such as pH, enzymes, gastrointestinal motility, etc. PDDS can be divided into three categories: time-controlled systems, where the delivery system controls drug release primarily; stimuli-induced systems, where release is programmed by external stimuli like magnetism, ultrasound, electrical effect, and irradiation; and externally regulated systems, where external stimuli like the pH or enzymes present in the intestinal tract or enzymes present in the drug delivery system control release. This article discusses several systems, such as capsular, osmotic, single- and multiple-unit systems based on soluble or erodible polymer covering and rupturable membranes. It summarizes the most recent technical innovations, formulation parameters, and system release profiles. This study also includes products available as once-daily formulations based on pulsatile releases, such as Pulsincap®, OROS®, CODAS®, and Pulsys®. These systems are helpful for medications with chronopharmacological behavior that need night-time dosage, pharmaceuticals with a first-pass solid action, and a particular location of absorption in the GIT. Diseases wherein PDDS are promising include asthma, peptic ulcer, cardiovascular ailments, arthritis, attention deficit syndrome in children, and hypercholesterolemia. PDDS can potentially bring new developments in the therapy of many diseases.
More Related Videos
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Bioavailability Enhancement: Drug Permeability Enhancement
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Factors Affecting Drug Distribution: Organ Perfusion Rate
Perfusion rate-limited distribution relies on the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

